PMC:7102662 / 12976-13470 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T34","span":{"begin":317,"end":322},"obj":"Body_part"},{"id":"T35","span":{"begin":357,"end":362},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma7088"},{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma7088"}],"text":"No study has described the incidence of ST-segment elevation myocardial infarction in COVID-19, but it appears to be low. Similarly, the incidence of left ventricular systolic dysfunction, acute left ventricular failure and cardiogenic shock have also not been described. Only one Chinese study reported incidence of heart failure in COVID-19 patients [5]. Heart failure had occurred in 52% of the patients who subsequently died and in 12% of the patients who were discharged from the hospital."}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T15","span":{"begin":317,"end":322},"obj":"Body_part"},{"id":"T16","span":{"begin":357,"end":362},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"uberon_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"A16","pred":"uberon_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"}],"text":"No study has described the incidence of ST-segment elevation myocardial infarction in COVID-19, but it appears to be low. Similarly, the incidence of left ventricular systolic dysfunction, acute left ventricular failure and cardiogenic shock have also not been described. Only one Chinese study reported incidence of heart failure in COVID-19 patients [5]. Heart failure had occurred in 52% of the patients who subsequently died and in 12% of the patients who were discharged from the hospital."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T126","span":{"begin":40,"end":82},"obj":"Disease"},{"id":"T127","span":{"begin":61,"end":82},"obj":"Disease"},{"id":"T128","span":{"begin":86,"end":94},"obj":"Disease"},{"id":"T129","span":{"begin":317,"end":330},"obj":"Disease"},{"id":"T130","span":{"begin":334,"end":342},"obj":"Disease"},{"id":"T131","span":{"begin":357,"end":370},"obj":"Disease"}],"attributes":[{"id":"A126","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0041656"},{"id":"A127","pred":"mondo_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/MONDO_0005068"},{"id":"A128","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A129","pred":"mondo_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/MONDO_0005252"},{"id":"A130","pred":"mondo_id","subj":"T130","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A131","pred":"mondo_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/MONDO_0005252"}],"text":"No study has described the incidence of ST-segment elevation myocardial infarction in COVID-19, but it appears to be low. Similarly, the incidence of left ventricular systolic dysfunction, acute left ventricular failure and cardiogenic shock have also not been described. Only one Chinese study reported incidence of heart failure in COVID-19 patients [5]. Heart failure had occurred in 52% of the patients who subsequently died and in 12% of the patients who were discharged from the hospital."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T80","span":{"begin":9,"end":12},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T81","span":{"begin":40,"end":42},"obj":"http://purl.obolibrary.org/obo/CLO_0009141"},{"id":"T82","span":{"begin":40,"end":42},"obj":"http://purl.obolibrary.org/obo/CLO_0050980"},{"id":"T83","span":{"begin":317,"end":322},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T84","span":{"begin":317,"end":322},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T85","span":{"begin":317,"end":322},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T86","span":{"begin":317,"end":322},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"},{"id":"T87","span":{"begin":357,"end":362},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T88","span":{"begin":357,"end":362},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T89","span":{"begin":357,"end":362},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T90","span":{"begin":357,"end":362},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"},{"id":"T91","span":{"begin":387,"end":389},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"}],"text":"No study has described the incidence of ST-segment elevation myocardial infarction in COVID-19, but it appears to be low. Similarly, the incidence of left ventricular systolic dysfunction, acute left ventricular failure and cardiogenic shock have also not been described. Only one Chinese study reported incidence of heart failure in COVID-19 patients [5]. Heart failure had occurred in 52% of the patients who subsequently died and in 12% of the patients who were discharged from the hospital."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T18","span":{"begin":40,"end":42},"obj":"Chemical"}],"attributes":[{"id":"A18","pred":"chebi_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/CHEBI_141393"}],"text":"No study has described the incidence of ST-segment elevation myocardial infarction in COVID-19, but it appears to be low. Similarly, the incidence of left ventricular systolic dysfunction, acute left ventricular failure and cardiogenic shock have also not been described. Only one Chinese study reported incidence of heart failure in COVID-19 patients [5]. Heart failure had occurred in 52% of the patients who subsequently died and in 12% of the patients who were discharged from the hospital."}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T33","span":{"begin":40,"end":60},"obj":"Phenotype"},{"id":"T34","span":{"begin":61,"end":82},"obj":"Phenotype"},{"id":"T35","span":{"begin":150,"end":187},"obj":"Phenotype"},{"id":"T36","span":{"begin":195,"end":219},"obj":"Phenotype"},{"id":"T37","span":{"begin":224,"end":241},"obj":"Phenotype"},{"id":"T38","span":{"begin":317,"end":330},"obj":"Phenotype"},{"id":"T39","span":{"begin":357,"end":370},"obj":"Phenotype"}],"attributes":[{"id":"A33","pred":"hp_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/HP_0012251"},{"id":"A34","pred":"hp_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/HP_0001658"},{"id":"A35","pred":"hp_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/HP_0025169"},{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0005162"},{"id":"A37","pred":"hp_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/HP_0030149"},{"id":"A38","pred":"hp_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/HP_0001635"},{"id":"A39","pred":"hp_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/HP_0001635"}],"text":"No study has described the incidence of ST-segment elevation myocardial infarction in COVID-19, but it appears to be low. Similarly, the incidence of left ventricular systolic dysfunction, acute left ventricular failure and cardiogenic shock have also not been described. Only one Chinese study reported incidence of heart failure in COVID-19 patients [5]. Heart failure had occurred in 52% of the patients who subsequently died and in 12% of the patients who were discharged from the hospital."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T106","span":{"begin":0,"end":121},"obj":"Sentence"},{"id":"T107","span":{"begin":122,"end":271},"obj":"Sentence"},{"id":"T108","span":{"begin":272,"end":356},"obj":"Sentence"},{"id":"T109","span":{"begin":357,"end":494},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"No study has described the incidence of ST-segment elevation myocardial infarction in COVID-19, but it appears to be low. Similarly, the incidence of left ventricular systolic dysfunction, acute left ventricular failure and cardiogenic shock have also not been described. Only one Chinese study reported incidence of heart failure in COVID-19 patients [5]. Heart failure had occurred in 52% of the patients who subsequently died and in 12% of the patients who were discharged from the hospital."}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T236","span":{"begin":61,"end":71},"obj":"UBERON:0002349"},{"id":"T237","span":{"begin":86,"end":94},"obj":"SP_7"},{"id":"T238","span":{"begin":150,"end":166},"obj":"UBERON:0002084"},{"id":"T239","span":{"begin":195,"end":211},"obj":"UBERON:0002084"},{"id":"T240","span":{"begin":317,"end":322},"obj":"UBERON:0000948"},{"id":"T241","span":{"begin":334,"end":342},"obj":"SP_7"},{"id":"T242","span":{"begin":357,"end":362},"obj":"UBERON:0000948"},{"id":"T243","span":{"begin":424,"end":428},"obj":"GO:0016265"},{"id":"T52612","span":{"begin":155,"end":166},"obj":"UBERON:0002082"},{"id":"T27094","span":{"begin":195,"end":211},"obj":"UBERON:0002084"},{"id":"T97008","span":{"begin":14,"end":19},"obj":"PR:000013883"},{"id":"T90587","span":{"begin":247,"end":255},"obj":"SP_7"},{"id":"T82666","span":{"begin":234,"end":246},"obj":"GO:0042730"},{"id":"T97480","span":{"begin":264,"end":272},"obj":"SP_7"},{"id":"T23223","span":{"begin":313,"end":323},"obj":"UBERON:0002349"},{"id":"T84766","span":{"begin":390,"end":400},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T62908","span":{"begin":424,"end":441},"obj":"CHEBI:48561;CHEBI:48561"},{"id":"T65791","span":{"begin":467,"end":475},"obj":"SP_7"}],"text":"No study has described the incidence of ST-segment elevation myocardial infarction in COVID-19, but it appears to be low. Similarly, the incidence of left ventricular systolic dysfunction, acute left ventricular failure and cardiogenic shock have also not been described. Only one Chinese study reported incidence of heart failure in COVID-19 patients [5]. Heart failure had occurred in 52% of the patients who subsequently died and in 12% of the patients who were discharged from the hospital."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"400","span":{"begin":343,"end":351},"obj":"Species"},{"id":"401","span":{"begin":398,"end":406},"obj":"Species"},{"id":"402","span":{"begin":447,"end":455},"obj":"Species"},{"id":"403","span":{"begin":61,"end":82},"obj":"Disease"},{"id":"404","span":{"begin":86,"end":94},"obj":"Disease"},{"id":"405","span":{"begin":150,"end":187},"obj":"Disease"},{"id":"406","span":{"begin":195,"end":219},"obj":"Disease"},{"id":"407","span":{"begin":224,"end":241},"obj":"Disease"},{"id":"408","span":{"begin":317,"end":330},"obj":"Disease"},{"id":"409","span":{"begin":334,"end":342},"obj":"Disease"},{"id":"410","span":{"begin":357,"end":370},"obj":"Disease"},{"id":"411","span":{"begin":424,"end":428},"obj":"Disease"}],"attributes":[{"id":"A400","pred":"tao:has_database_id","subj":"400","obj":"Tax:9606"},{"id":"A401","pred":"tao:has_database_id","subj":"401","obj":"Tax:9606"},{"id":"A402","pred":"tao:has_database_id","subj":"402","obj":"Tax:9606"},{"id":"A403","pred":"tao:has_database_id","subj":"403","obj":"MESH:D009203"},{"id":"A404","pred":"tao:has_database_id","subj":"404","obj":"MESH:C000657245"},{"id":"A405","pred":"tao:has_database_id","subj":"405","obj":"MESH:D018487"},{"id":"A406","pred":"tao:has_database_id","subj":"406","obj":"MESH:D018487"},{"id":"A407","pred":"tao:has_database_id","subj":"407","obj":"MESH:D012770"},{"id":"A408","pred":"tao:has_database_id","subj":"408","obj":"MESH:D006333"},{"id":"A409","pred":"tao:has_database_id","subj":"409","obj":"MESH:C000657245"},{"id":"A410","pred":"tao:has_database_id","subj":"410","obj":"MESH:D006333"},{"id":"A411","pred":"tao:has_database_id","subj":"411","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"No study has described the incidence of ST-segment elevation myocardial infarction in COVID-19, but it appears to be low. Similarly, the incidence of left ventricular systolic dysfunction, acute left ventricular failure and cardiogenic shock have also not been described. Only one Chinese study reported incidence of heart failure in COVID-19 patients [5]. Heart failure had occurred in 52% of the patients who subsequently died and in 12% of the patients who were discharged from the hospital."}